PATENT CLAIM ANALYSIS

Application Number: 15989734
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of conditions such as arthritis.

Claim (Index 11):
The method of  claim 10 , wherein about 30 mg to about 50 mg of esomeprazole is present in the solid dosage form.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15986215', '15902770', '15988104', '15132130', '15984055']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8132743682418911
- 35 USC 102 Novelty (BERT): 0.6411280115963782
- Combined Prediction Score: 0.7960597325773399
- Mean Citation Score: 403.163756
- Max Citation Score: 418.40036
- Similarity Product: 367.1698569454169

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test